Mathieu C, Dandona P, Birkenfeld AL, Krarup Hansen T, et al. Benefit:Risk Profile of Dapagliflozin 5 mg in the DEPICT-1 and -2 Trials in Individuals with Type 1 Diabetes and BMI >/=27 kg/m(2). Diabetes Obes Metab 2020 Jul 20. doi: 10.1111/dom.14144.
PMID: 32691513